Caplight Directory>Companies>Muna Therapeutics-preview>Muna-therapeutics


Muna Therapeutics

Muna Therapeutics

Private
Copenhagen, Capital Region of DenmarkHealthcare & Life Scienceshttps://www.munatherapeutics.com

Last Round

Strategic

Dec 5, 2024

Total Funding Raised

$112.9M

Momentum Score

50 /100

Company Overview

Muna Therapeutics is a biopharmaceutical company focused on discovering and developing therapies aimed at slowing or halting the progression of neurodegenerative diseases.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology, Clinical Trials, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting, Revenue Share, Government Contracts

AI Layer

Non-AI

Keywords

small molecule therapeuticsneurodegenerative diseasesdrug discovery platformneuroinflammationAlzheimer's diseaseParkinson's diseasedrug target identificationspatial biologypharma partnershipsmulti-omics platformCNS therapeuticsTREM2 agonismKv1.3 blockadeclinical-stage biotechdrug discovery enginehuman tissue platformdrug licensing

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Muna Therapeutics Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Muna Therapeutics Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
StrategicDec 5, 2024
GrantOct 11, 2022
Series AJul 9, 2021
View all Funding Rounds

Muna Therapeutics Investors

Notable investors and investment history

InvestorRounds
EQT Life SciencesSeries A
LF InvestmentsSeries A
AxxamSeries A
Droia VenturesSeed, Series A
V-Bio VenturesSeries A
Novo HoldingsSeed, Series A
The Michael J. Fox Foundation for Parkinson's ResearchGrant
View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 16, 2026

    Monthly visitors grew 266% MoM, reaching 18.9K.

View all signals

Muna Therapeutics Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Muna Therapeutics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Muna Therapeutics's valuation, stock price, and market status.

Firmographic Details

HeadquartersCopenhagen, Capital Region of Denmark
Employee Range55
Year Founded2020
Last FundingDec 5, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.





Caplight Logo




Use CasesInvestorsEmployees

CompaniesAll Companies

LegalPrivacy PolicyTerms of UseBrokerCheckForm CRS


Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.